United States · 
Who invested in Grove Biopharma?
Grove Biopharma's investors include DCVC, Eli Lilly and DeepWork Capital.
United States · Series A startup
Who invested in Grove Biopharma
Funding summaryUpdated 26 Oct 2026
$30Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $30MApr 2025
- Investors
- 3
The rounds
- Apr 2025
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
These 2 firms list Grove Biopharma as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Grove Biopharma
How much has Grove Biopharma raised?
Grove Biopharma has raised $30M across 1 round since 2025.
When did Grove Biopharma last raise?
Grove Biopharma's most recent round was a Series A of $30M in Apr 2025.
What was Grove Biopharma's biggest round?
Its most recent round, $30M in Apr 2025, is also its largest on record.
Who backed Grove Biopharma first?
Grove Biopharma's first round on record, in Apr 2025, was backed by DCVC, Eli Lilly and DeepWork Capital.
What stage is Grove Biopharma at?
Grove Biopharma's latest named round is a Series A, in Apr 2025.
Where is Grove Biopharma based?
Grove Biopharma is based in the United States.
Companies like Grove Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.